Literature DB >> 9040838

Seroprevalence of antibodies to Sarcocystis neurona in horses residing in a county of southeastern Pennsylvania.

B G Bentz1, D E Granstrom, S Stamper.   

Abstract

OBJECTIVE: To determine seroprevalence of Sarcocystis neurona-specific antibodies in a population of horses residing in Chester County, Pa.
DESIGN: Prevalence survey. SAMPLE POPULATION: 117 serum samples from selected members of a population of 580 Thoroughbred horses. PROCEDURE: Serum was analyzed for antibodies to Sarcocystic neurona, using a western blot. Information regarding age, sex, and housing of horse was obtained by questionnaire. Data were analyzed, using multivariable logistic regression.
RESULTS: Seroprevalence was 45.3% (95% CI, 36.3 to 54.3%). A relationship was not found between seroprevalence and sex of horse. Seroprevalence was greater in older horses (logistic regression; P = 0.16). CLINICAL IMPLICATIONS: High seroprevalence of antibodies to S neurona and the lack of neurologic deficits among horses sampled indicate that positive results of serologic examination alone are of limited value for diagnosis of equine protozoal myeloencephalitis. Clinical signs consistent with the disease are the most important consideration in accurate diagnosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9040838

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  7 in total

1.  Evidence that surface proteins Sn14 and Sn16 of Sarcocystis neurona merozoites are involved in infection and immunity.

Authors:  F T Liang; D E Granstrom; X M Zhao; J F Timoney
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

2.  Enzyme-linked immunosorbent assays for detection of equine antibodies specific to Sarcocystis neurona surface antigens.

Authors:  Jessica S Hoane; Jennifer K Morrow; William J Saville; J P Dubey; David E Granstrom; Daniel K Howe
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

3.  Reduced levels of nitric oxide metabolites in cerebrospinal fluid are associated with equine protozoal myeloencephalitis.

Authors:  Chinedu J Njoku; William J A Saville; Stephen M Reed; Michael J Oglesbee; Päivi J Rajala-Schultz; Roger W Stich
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

Review 4.  An update on Sarcocystis neurona infections in animals and equine protozoal myeloencephalitis (EPM).

Authors:  J P Dubey; D K Howe; M Furr; W J Saville; A E Marsh; S M Reed; M E Grigg
Journal:  Vet Parasitol       Date:  2015-02-07       Impact factor: 2.738

5.  Cytokine gene expression in response to SnSAG1 in horses with equine protozoal myeloencephalitis.

Authors:  Jennifer A Spencer; Patricia Deinnocentes; Edith M Moyana; Anthony J Guarino; Siobhan E Ellison; R Curtis Bird; Byron L Blagburn
Journal:  Clin Diagn Lab Immunol       Date:  2005-05

6.  Prevalence of antibodies to Sarcocystis neurona and Neospora hughesi in horses from Mexico.

Authors:  Michelle R Yeargan; Cosme Alvarado-Esquivel; Jitender P Dubey; Daniel K Howe
Journal:  Parasite       Date:  2013-09-10       Impact factor: 3.000

Review 7.  Equine Protozoal Myeloencephalitis: An Updated Consensus Statement with a Focus on Parasite Biology, Diagnosis, Treatment, and Prevention.

Authors:  S M Reed; M Furr; D K Howe; A L Johnson; R J MacKay; J K Morrow; N Pusterla; S Witonsky
Journal:  J Vet Intern Med       Date:  2016-02-09       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.